Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New statement proposes ways to stop deadly drug errors among heart, stroke patients

12.11.2002


Better educating physicians, using computers to order drugs and improving the system for policing inappropriate medication use can help reduce potentially deadly errors among cardiovascular patients, according to a new American Heart Association scientific statement published in today’s Circulation: Journal of the American Heart Association.



Several reports have blamed medical errors for thousands of adverse events and deaths among patients in recent years. One study estimates that medical errors occur in 3.7 percent to 16.6 percent of hospitalized patients, contributing to at least 44,000 deaths in the United States each year. Data on deaths due to medical errors involving heart disease and stroke patients is more limited, but a small study of 182 deaths from cerebrovascular disease, pneumonia or heart attack suggests that 14 percent to 27 percent of the deaths may have been avoidable.

Additionally, a study of 203 cases of cardiac arrest concluded that about 7 percent of the arrests may have been prevented, says Jane E. Freedman, M.D., a member of the American Heart Association’s Committee on Acute Cardiac Care and lead author of the statement. Medication error was the most common cause of potentially preventable arrest, occurring in 44 percent of cases. Mistakes can be made while prescribing, transcribing, dispensing, administering or monitoring medication. Sometimes the incorrect drug is prescribed or dispensed, while other times drug dosages are so high that they are toxic. Another error is creating a dangerous combination with other drugs.


Noting the small size of the studies, Freedman says, "There really isn’t any good general data regarding death caused by medication error among cardiovascular patients. But whatever the exact figures are, it is clear from what we know that patient safety can be improved.

"We need to figure out how to best police errors and develop a system to evaluate how big a problem medical errors are in cardiac care," says Freedman, an associate professor of medicine, pharmacology and experimental therapeutics at Boston University School of Medicine.

According to The National Coordinating Council for Medication Error and Prevention, a medication error is ". . .any preventable event that may cause or lead to inappropriate medication use or patient harm, while the medication is in the control of the health care professional, patient, or consumer."

Recommendations for reducing deaths due to medication error highlighted in the statement include: · Improve reporting of medication errors.

Staff self-reporting, currently the most common method of reporting errors, catches fewer than half of adverse events, Freedman says. "Many doctors are afraid of litigation, a dilemma that must be addressed as part of the overall solution."

· Develop a system to control errors.

"Computers are helping," Freedman says. "Some hospitals, for example, have computerized systems that say, ’Don’t use these two drugs together.’"

Other suggestions: Use streamlined protocols that consider all recent drugs the patient has been prescribed. Also, use standardized order forms that include prompts to record a patient’s weight if needed to calculate the correct dosage.

· Improve education.

"We have to better train doctors to be aware of drugs with similar names," she says. For example, the calcium channel blocker Cardene can be confused with the calcium channel blockers Cardizem or Cardizem SR, or the narcotic codeine.

Physicians should refer to fibrinolytic or clot-dissolving drugs by their full generic or brand names and avoid abbreviations even in their handwritten orders.

Doctors also need to be educated about using newer medications. For example, if a new, low-molecular weight heparin is substituted for traditional unfractionated heparin, the dosage of other medications may change too, she notes.

· Address errors of omission.

"While not always considered a safety error, this is a big problem in cardiac care," Freedman says. "Studies show that not everyone leaving the hospital who should be getting potentially lifesaving medications such as beta blockers or aspirin are getting them."

Finally, Freedman says, adverse events occur due to poor handwriting. "If you scribble a prescription rather than type it, the chances of medication error are so much greater," she says. "This error should never happen."


Coauthors are Richard C. Becker, M.D.; Jesse E. Adams, M.D.; Steven Borzak, M.D.; Robert L. Jesse, M.D.; L. Kristin Newby, M.D.; Patrick O’Gara, M.D.; John C. Pezzullo, M.D.; Richard Kerber, M.D.; Bernice Coleman, M.D.; Joseph Broderick, M.D.; Sally Yasuda, M.D.; and Christopher Cannon, M.D.

Carole Bullock | EurekAlert!
Further information:
http://www.americanheart.org/

More articles from Health and Medicine:

nachricht Vanishing capillaries
23.03.2017 | Technische Universität München

nachricht How prenatal maternal infections may affect genetic factors in Autism spectrum disorder
22.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

When Air is in Short Supply - Shedding light on plant stress reactions when oxygen runs short

23.03.2017 | Life Sciences

Researchers use light to remotely control curvature of plastics

23.03.2017 | Power and Electrical Engineering

Sea ice extent sinks to record lows at both poles

23.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>